ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1021–1032 of 2020 project topics
22q11 Deletion Syndrome Cardiac Phenotype Genetics
Studying TBX1 and other genes in the 22q11 deletion region contributing to conotruncal heart defects for understanding molecular mechanisms.
Genetic Basis of Congenital Heart Defects Click to view more details →
NOTCH1 Bicuspid Aortic Valve Variant Analysis
Characterizing NOTCH1 pathogenic variants causing bicuspid aortic valve and associated aortopathy for family-based cardiac surveillance programs.
Genetic Basis of Congenital Heart Defects Click to view more details →
CHD Gene Discovery by Large Scale Sequencing
Using whole genome sequencing in large CHD cohorts for identifying novel genes and pathways causing congenital heart defects.
Genetic Basis of Congenital Heart Defects Click to view more details →
Heterotaxy and Laterality Defect Gene Analysis
Testing ZIC3, CFC1, NODAL, and other laterality genes in patients with heterotaxy and complex heart malformations with situs anomalies.
Genetic Basis of Congenital Heart Defects Click to view more details →
TBX5 Holt-Oram Syndrome Variant Classification SaaS
A cloud-based platform that automatically classifies TBX5 genetic variants and predicts cardiac manifestations in Holt-Oram syndrome using machine learning models trained on curated clinical databases. This enables genetic counselors and cardiologists to provide faster, evidence-based risk stratification for patients, reducing diagnostic timelines and enabling early intervention strategies.
Genetic Basis of Congenital Heart Defects Click to view more details →
MYH6 Atrial Septal Defect Predictive Analytics Tool
An AI-powered diagnostic tool that analyzes MYH6 mutations to predict atrial septal defect severity and surgical outcomes with high accuracy. Hospitals and cardiac centers use this tool to optimize patient stratification and treatment planning, creating new revenue streams through premium diagnostic services.
Genetic Basis of Congenital Heart Defects Click to view more details →
GATA4 Ventricular Septal Defect Genotype-Phenotype Mapping
A specialized bioinformatics platform that maps GATA4 variants to specific ventricular septal defect phenotypes and prognosis using integrated genomic and clinical datasets. Commercial labs and genetic testing companies monetize this through enhanced reporting capabilities and higher-margin personalized medicine services.
Genetic Basis of Congenital Heart Defects Click to view more details →
Conotruncal Defect Gene Panel Commercial Testing Suite
A comprehensive genetic testing service and laboratory information management system targeting tetralogy of Fallot and transposition of the great arteries with simultaneous analysis of 50+ causal genes. This product generates recurring revenue through high-volume testing orders while establishing clinical utility benchmarks in the cardiac genetic testing market.
Genetic Basis of Congenital Heart Defects Click to view more details →
HAND1 Left Ventricular Hypoplasia Risk Stratification Engine
A proprietary software engine that integrates HAND1 genetic data with imaging analytics to stratify left ventricular hypoplasia progression and transplantation risk in pediatric patients. This supports precision medicine initiatives and generates licensing revenue through partnerships with major cardiac centers and telemedicine platforms.
Genetic Basis of Congenital Heart Defects Click to view more details →
Chromatin Remodeling CHD Genes Clinical Interpretation Database
A commercial variant interpretation database and API that specializes in BAF, CHD7, and other chromatin remodeling gene variants associated with congenital heart defects, offering real-time clinical evidence updates. Genetic laboratories and healthcare systems subscribe to this SaaS solution to improve diagnostic accuracy and reduce liability from variant misclassification.
Genetic Basis of Congenital Heart Defects Click to view more details →
Regulatory Variant Prioritization by Epigenomics
Using tissue-specific ATAC-seq and ChIP-seq data for prioritizing non-coding variants in active regulatory elements for functional investigation.
Functional Annotation of Non-Coding Genome Click to view more details →
MPRA for Non-Coding Variant Functional Testing
Applying massively parallel reporter assays for high-throughput functional testing of regulatory variants identified by GWAS and sequencing.
Functional Annotation of Non-Coding Genome Click to view more details →